serw-MX  [xml]  
 
    
 DeCS Categories

D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.385 Isoxazoles .
D03.383.129.385.650 Paliperidone Palmitate .
D03.383.621 Piperidines .
D03.383.621.808 Piperidones .
D03.383.621.808.250 Dexetimide .
D03.383.742 Pyrimidines .
D03.383.742.592 Paliperidone Palmitate .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.685 Risperidone .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.852 Receptors, Cytokine .
D12.776.543.750.705.852.760 Receptors, Tumor Necrosis Factor .
D12.776.543.750.705.852.760.345 Receptor Activator of Nuclear Factor-kappa B .
G05 Genetic Phenomena .
G05.360 Genetic Structures .
G05.360.340 Genome .
G05.360.340.024 Genome Components .
G05.360.340.024.340 Genes .
G05.360.340.024.340.364 Genes, Microbial .
G05.360.340.024.340.364.875 Genes, Viral .
G05.360.340.024.340.364.875.897 Genes, vpr .
G05.360.340.024.340.425 Genes, Regulator .
G05.360.340.024.340.425.578 Genes, vpr .
G05.360.340.358 Genome, Microbial .
G05.360.340.358.024 Genes, Microbial .
G05.360.340.358.024.875 Genes, Viral .
G05.360.340.358.024.875.897 Genes, vpr .
G05.360.340.358.840 Genome, Viral .
G05.360.340.358.840.500 Genes, Viral .
G05.360.340.358.840.500.897 Genes, vpr .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Paliperidone Palmitate .
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one .
9-Hydroxy-risperidone .
9-Hydroxyrisperidone .
9-OH-risperidone .
Invega .
Invega Sustenna .
Paliperidone .
R 76477 .
R-76477 .
9 Hydroxy risperidone .
9 Hydroxyrisperidone .
9 OH risperidone .
Palmitate, Paliperidone .
R76477 .
Sustenna, Invega .
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA. .
1.00
 
Dexetimide .
Dexbenzetimid .
R-16470 .
Spasmentral .
Tremblex .
dextro-Benzetimide .
R 16470 .
R16470 .
dextro Benzetimide .
Benzetimide .
Dexbenzetimide .
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide. .
0.37
 
Genes, vpr .
vpr Gene .
Gene, R .
Gene, rap .
Gene, vpr .
R Gene .
R Genes .
rap Gene .
rap Genes .
vpr Genes .
Genes, rap .
Genes, R .
DNA sequences that form the coding region for a trans-activator protein that specifies rapid growth in human immunodeficiency virus (HIV). vpr is short for viral protein R, where R is undefined. .
0.36
 
Risperidone .
R-64,766 .
R-64766 .
Risperdal Consta .
Risperidal .
Consta, Risperdal .
R 64,766 .
R 64766 .
R64,766 .
R64766 .
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. .
0.36
 
Receptor Activator of Nuclear Factor-kappa B .
CD265 Antigen .
NF-KappaB Receptor Activator .
RANK Protein .
Receptor Activator of NF-kappa B .
Receptor Activator of NF-kappaB .
Receptor Activator of Nuclear Factor-kappaB .
TNFRSF11A Protein .
TRANCE Receptor .
TRANCE-R .
Activator, NF-KappaB Receptor .
Antigen, CD265 .
NF Kappa B Receptor Activator .
NF KappaB Receptor Activator .
Receptor Activator of NF kappa B .
Receptor Activator of NF kappaB .
Receptor Activator of Nuclear Factor kappa B .
Receptor Activator of Nuclear Factor kappaB .
Receptor Activator, NF-KappaB .
TRANCE R .
NF-Kappa B Receptor Activator .
Receptors, Tumor Necrosis Factor, Member 11a .
Tumor Necrosis Factor Receptor Superfamily, Member 11a .
A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. .
0.35